BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.430
-0.050 (-3.38%)
At close: May 13, 2025, 4:00 PM
1.370
-0.060 (-4.20%)
Pre-market: May 14, 2025, 5:46 AM EDT

BioXcel Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Cash & Equivalents
31.0129.8565.22193.73232.97213.12
Upgrade
Cash & Short-Term Investments
31.0129.8565.22193.73232.97213.12
Upgrade
Cash Growth
-58.17%-54.23%-66.33%-16.84%9.31%557.25%
Upgrade
Accounts Receivable
-0.130.070.25--
Upgrade
Receivables
-0.130.070.25--
Upgrade
Inventory
0.640.681.991.99--
Upgrade
Prepaid Expenses
4.745.292.783.072.892.96
Upgrade
Other Current Assets
1.391.442.083.840.960.98
Upgrade
Total Current Assets
37.7837.3972.14202.87236.81217.07
Upgrade
Property, Plant & Equipment
0.70.861.472.062.542.78
Upgrade
Other Long-Term Assets
0.090.090.090.930.090.09
Upgrade
Total Assets
38.5738.3473.7205.85239.44219.94
Upgrade
Accounts Payable
15.4515.9913.6510.234.683.98
Upgrade
Accrued Expenses
3.995.7813.1522.1811.396.93
Upgrade
Current Portion of Leases
-0.37----
Upgrade
Current Income Taxes Payable
-0.090.120.080.30.7
Upgrade
Other Current Liabilities
0.5-0.350.40.290.24
Upgrade
Total Current Liabilities
25.5522.2327.2732.916.6711.84
Upgrade
Long-Term Debt
99.92102.51100.693.05--
Upgrade
Long-Term Leases
-0.070.440.791.111.4
Upgrade
Other Long-Term Liabilities
3.276.631.912.34--
Upgrade
Total Liabilities
128.74131.44130.21129.0817.7713.24
Upgrade
Common Stock
0.060.050.030.030.030.02
Upgrade
Additional Paid-In Capital
567.22557.05534.06488.29467.43345.53
Upgrade
Retained Earnings
-657.45-650.2-590.6-411.55-245.79-138.86
Upgrade
Shareholders' Equity
-90.17-93.1-56.5176.78221.67206.7
Upgrade
Total Liabilities & Equity
38.5738.3473.7205.85239.44219.94
Upgrade
Total Debt
105.53102.95101.0493.841.111.4
Upgrade
Net Cash (Debt)
-74.51-73.09-35.8299.89231.86211.72
Upgrade
Net Cash Growth
----56.92%9.51%574.34%
Upgrade
Net Cash Per Share
-22.85-28.83-19.6757.05140.67156.23
Upgrade
Filing Date Shares Outstanding
6.065.491.911.811.751.54
Upgrade
Total Common Shares Outstanding
5.473.11.871.761.751.53
Upgrade
Working Capital
12.2315.1644.88169.97220.15205.22
Upgrade
Book Value Per Share
-16.49-30.01-30.2143.64126.76135.44
Upgrade
Tangible Book Value
-90.17-93.1-56.5176.78221.67206.7
Upgrade
Tangible Book Value Per Share
-16.49-30.01-30.2143.64126.76135.44
Upgrade
Machinery
-0.780.780.790.740.63
Upgrade
Construction In Progress
----0.020.36
Upgrade
Leasehold Improvements
-1.21.21.181.130.65
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q